BioCentury
ARTICLE | Clinical News

Adeza regulatory update

April 10, 1995 7:00 AM UTC

The FDA's Clinical Chemistry and Toxicology Advisory Committee recommended marketing approval of Adeza's diagnostic test for fetal fibronectin (fFN) that aids in detecting impending preterm delivery. ...